Cellerant Therapeutics Secures $2,190,000 New Financing

  • Feed Type
  • Date
    1/23/2014
  • Company Name
    Cellerant Therapeutics
  • Mailing Address
    1561 Industrial Road San Carlos, CA 94070
  • Company Description
    Cellerant Therapeutics Inc. is a clinical-stage biotechnology company developing and commercializing the use of hematopoietic (blood-forming) stem cell-based therapies for the treatment of a variety of cancers and autoimmune diseases.
  • Website
    http://www.cellerant.com
  • Transaction Type
    Debt
  • Transaction Amount
    $2,190,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Includes conversion of $1,144,342 of previous indebtedness. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.